Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, National Institute of Health, 00199 Rome, Italy.
Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers' Compensation Authority, 00078 Roma, Italy.
Int J Environ Res Public Health. 2021 Sep 15;18(18):9709. doi: 10.3390/ijerph18189709.
Workers with cardiac active implantable medical devices (AIMD), such as a pacemaker (PM) or an implantable defibrillator (ICD), are considered by the occupational health and safety regulation framework as a particularly sensitive risk group that must be protected against the dangers caused by the interference of electromagnetic field (EMF). In this paper, we first describe the general methodology that shall be followed for the risk assessment of employees with a cardiac AIMD exposed to EMF, according to the EU regulation, and in particular to the EN 50527-2-1:2016 and 50527-2-2:2018 standards. Then, three case studies related to specific EMF sources are presented, to better describe how the initial analysis of the risk assessment can be performed in practice, and to understand if a further specific risk assessment analysis is required or not.
患有心脏活性植入式医疗器械（AIMD）的工人，如起搏器（PM）或植入式除颤器（ICD），被职业健康和安全法规框架视为一个特别敏感的风险群体，必须防止电磁场（EMF）干扰造成的危险。在本文中，我们首先描述了根据欧盟法规，特别是 EN 50527-2-1:2016 和 50527-2-2:2018 标准，对暴露于电磁场的患有心脏 AIMD 的员工进行风险评估所应遵循的一般方法。然后，提出了三个与特定电磁场源相关的案例研究，以更好地描述如何在实践中进行风险评估的初步分析，并了解是否需要进一步进行特定的风险评估分析。
